Diasorin | DIA - Operating Expenses

Stock Price
70.46
Daily Change
1.00 1.44%
Monthly
13.46%
Yearly
-25.93%
Q2 Forecast
68.63

Diasorin reported EUR231M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Amplifon EUR 600.86M 61.82M Dec/2025
Avanos Medical USD 782.1M 625.97M Mar/2026
Brookdale Senior Living USD -55.93M 782.65M Mar/2026
Cencora USD 84.92B 2.15B Dec/2025
Diasorin EUR 231M 511K Mar/2026
Encompass Health USD 1.27B 6.3M Mar/2026
Enovis USD 579.91M 6.59M Mar/2026
GE HealthCare Technologies USD 4.82B 408M Dec/2025
OPKO Health USD 186.77M 18.42M Dec/2025
Pediatrix Medical Group USD 439.1M 20.23M Dec/2025
Veradigm USD 188M 61.08M Dec/2022
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026